Psychiatry AtlasMedication guide · United States

Nonstimulant ADHD medicine

Clonidine (Kapvay, Onyda XR)

Generic name
clonidine (as clonidine hydrochloride)
Brand names
Kapvay; Onyda XR
Medication class
Nonstimulant ADHD medicine
Forms covered
Extended-release oral tablets for ADHD; Onyda XR extended-release oral suspension

Article updated: 2026-10-24 · Sources last checked: 2026-11-05

Medication Safety Alerts

Look-alike / sound-alike name

High Alert

  • Children taking Onyda XR liquid in community/ambulatory care: measurement errors can cause serious harm. Use the supplied oral syringe and prescribed volume.

Clonidine extended-release treats ADHD alone or alongside a stimulant. Generic ER tablets and Onyda XR liquid are different products with different schedules; their pediatric use begins at age 6.

Kapvay (discontinued ER-tablet brand; generic alternatives exist).

What to expect: ADHD benefit is assessed during regular treatment and gradual dose adjustments over several weeks.

Warning signs · Medicine forms
Sources last checked:
2026-11-05

What is this medicine used for?

FDA-approved uses

  • Attention-deficit/hyperactivity disorder (ADHD) — Children and adolescents aged 6–17 for the ER tablet; pediatric patients aged 6 years and older for Onyda XR. Used alone or alongside a stimulant. ER tablets and Onyda XR liquid have different schedules and must not be substituted milligram for milligram.Extended-release oral tablets for ADHD; Onyda XR extended-release oral suspension.

What should I expect?

ADHD benefit is assessed during regular treatment and gradual dose adjustments over several weeks. Look for changes in attention, impulsivity and everyday functioning rather than assuming that being sleepy means the medicine is helping.

Drowsiness and dizziness can start early. Keep the planned follow-up and contact the prescriber sooner if these effects interfere with daily activities or improvement is not developing.

How do I take it safely?

Swallow ER tablets whole; never cut, crush or chew them. Follow the prescribed tablet schedule. Onyda XR is a separate once-nightly liquid and must not be substituted milligram for milligram.

Gently shake Onyda XR up and down for at least 10 seconds, avoiding foam, and measure with its supplied oral dispenser. Follow the bottle-specific discard date after opening: 30 days for 30- or 60-mL bottles and 60 days for 120-mL bottles.

Monitor pulse and blood pressure before treatment, after increases and periodically. Avoid dehydration, overheating and driving while sleepy or dizzy.

Avoid alcohol and have sedatives, blood-pressure medicines, heart-rate medicines and antidepressants checked for interactions. Do not change these medicines yourself to compensate for a low pulse or pressure.

Skip a missed ER ADHD dose and take the next on schedule; do not catch up. Do not abruptly stop regular treatment. Ask the prescriber about a gradual reduction or repeated missed doses.

Report prior clonidine allergy, including a patch reaction, heart-conduction problems or kidney disease. Discuss pregnancy and breastfeeding; clonidine enters milk, and unusual infant sleepiness, poor feeding or breathing pauses need assessment.

What side effects should I know about?

  • Sleepiness, fatigue, dizziness or headache.
  • Dry mouth, constipation, irritability or sleep-related symptoms.

Tell your prescriber about effects that are persistent, troublesome, or interfere with daily life.

Which warning signs need help?

  • Fainting, marked drowsiness or a very slow pulse needs urgent assessment.
  • Severe headache, confusion or chest symptoms after missed doses or abrupt stopping may reflect dangerously high blood pressure; get emergency assessment.
  • Get emergency help for trouble breathing, swelling of the tongue or throat, collapse, a seizure or inability to wake. Suspected overdose needs immediate poison-center or emergency advice; do not wait for symptoms.

What else should I know to stay safe?

  • Previous clonidine allergy, including a patch allergy, needs assessment before oral use. Heart-conduction problems and kidney disease require extra care; monitor pulse and blood pressure before treatment, after increases and periodically.
  • Avoid alcohol, unreviewed sedatives, dehydration and overheating. Have blood-pressure and heart-rate medicines checked, and do not drive while impaired. Clonidine formulations must not be exchanged milligram for milligram.
  • Do not abruptly stop regular treatment or change other heart medicines yourself. Arrange a supervised reduction and seek advice when illness prevents regular treatment. Discuss pregnancy and breastfeeding; clonidine enters milk, and infants need observation for sedation, poor feeding or breathing changes.

Urgent help and crisis support · Emergency & Crisis Resources (US)

What can help day to day?

  • The ER liquid is taken once nightly; the ER tablet may be prescribed in divided doses. Even two long-acting products are not automatically interchangeable.
  • A caregiver can make dosing safer by recording each dose and keeping the supplied liquid dispenser with the bottle.
  • Stopping suddenly can cause a sharp blood-pressure rise. Illness that prevents regular dosing is a reason to contact the prescribing team.

How does it work?

Clonidine activates alpha-2 receptors, proteins in the brain that respond to chemical messages. This can reduce nerve signals that make the heart beat faster and blood vessels tighten. Although these body effects are understood, its complete mechanism for improving attention-deficit/hyperactivity disorder (ADHD) symptoms is not established.

Explore medication science

How was this medicine developed?

Clonidine first received US approval in 1974, before its ADHD formulations existed. The later extended-release tablet application received ADHD-related indication changes in 2010; Onyda XR added an extended-release liquid option in 2024.

How do I say the name?

Clonidine: KLOH-nih-deen. Capital letters show the stressed syllable.

Medicine forms and official information

Match the full name, release type and route on your prescription. Different formulations need their own prescribing instructions; do not switch or substitute them yourself.

Sources and References

Sources support the U.S. products described here. Product instructions can differ; use the information supplied with your own medicine.

  1. Clonidine hydrochloride ER tablets: current prescribing information
  2. Kapvay: FDA approval and discontinued product history
  3. Onyda XR: current ER oral suspension label
  4. Clonidine: patient information and historical brands
  5. Onyda XR: FDA approval and labeling history
  6. Kapvay: FDA reference-product label
  7. Onyda XR: Package Insert / Prescribing Information / MOA
  8. Onyda XR: FDA prescribing information
  9. Intuniv: current guanfacine ER label
  10. Clonidine: verified parent compound, PubChem CID 2803
  11. ISMP List of Confused Drug Names
  12. ISMP List of High-Alert Medications in Community/Ambulatory Care Settings

Giving medicine safely to children: family guide (PDF, 3 pages)

How information is checked

Was this article helpful?

Was this article helpful?

Sends your choice, article identifier, edition and optional issue to Psychiatry Atlas. No name, email or medical details are requested. Daily network codes help prevent spam; hosting may process technical information. This is not a promise of anonymity. Privacy details.

Enable JavaScript to send feedback.

Suggest a missing topic or describe a correction. Please keep personal medical information out of website feedback.

Back to top